Inve US ▾
AA

Agilent (A) Q1 FY26 earnings call

Earnings call· Jan 2026 (Q1 FY26)· Health Care· Feb 25, 2026

Source: earnings call transcript

Agilent delivered a solid start to FY26, with strong core revenue growth driven by robust performance in pharma and chemicals and advanced materials, despite a $10 million weather-related revenue impact. The company maintained its full-year guidance, anticipating continued momentum from key markets, new product innovations, and the Ignite Operating System to drive margin expansion and long-term value. Management expressed confidence in the underlying business trends and strategic initiatives.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.